Genomic Health Inc. Message Board
-
"annoy me"? You have to take someone seriously first.... - )
I LIKE the SI increase -
accurate =Gilead's cystic fibrosis drug Cayston =Analysts predict that Cayston MAY achieve annual sales of $161.7 million by 2014. TOBI sales last year were aprx 75M.
Wedbush predicted 35-45 M for Arikace
Timeline is unknown until Insmed decides on the EU results if they want to do a P3 in the U.S. Good Luck - Reply to
To the wannabe what terry_insm posted and did not post
by jay_mahavorick •Mar 11, 2013 2:25 PMThe chart no lie =Thanks for the kind words and yes the chart did indeed go long last week so I covered and will wait to see how they want to play this.Analysts often enter with a manipulative call (note the buying with no analysts).I GUESS they will move it up for a Phase3 ....dump,but we shall see. fyi-the 65 cent price is the same as 2+1/2 years ago when Insmed became Arikace....... YTD +22% and waiting...
-
jay travelin then wait for 644 adios
-
These numbers are true.Wedbushs # of CF as a small product have long been quoted. Ah 2 thumbs for not posting Billions lol!
-
Chart last week told the tale and finally a need analyst.Leerick is a good one.
On the sidelines YTD+22%............ this makes INSM easier to trade Good Luck -
thank me for the runup yesterday.covrd 80% YTD+22%
too many soaring bios to be invested on unproductive capital on INSM lo vol
from the hotel where they made the movie "10"
senor~ -
first solar etc ..busy
8 day MA is very accurate considering this stock has no movement,
I believe there is very few retail and maybe one MM involved.(pssin out 100 shares S&M trades
TIBX PAY and FSLR all before my plane takes off... and pays for my holiday
email unfortunately only goes one way
Good Luck -
Tradestation
-
disappointing but not surprising
Why would anyone spend their money on a risky biotech when there are a gazillion stocks making money?
covering soon.,almost zero volume
Good Luck
Tim,you promised! ; ) -
CREE + 1.79 and out / lunch money
buh bye and Have a nice day -
funny
CREE -
zake1 posts "analysts forecast the Global Inhaled Antibiotics market to reach US$875 million by 2015
Insmeds will be able to capture? what % of that market
What is the current Insmed,Inc current support position and hence effect on shareholder value?
with regards to Iplex?
because you lost money on Iplex,you decided to double down on Arikace, do you think this wise?
Good Luck -
1k +.33 PRAN and out
dare I say anything to anyone that misconstude but the chart will test another level and I will look to cover most as there are just too many better buys in the market
YTD - Up 23% short since $7.81
Good Luck -
"you...posting that we should see $600 per share in the next few years, and why isn't INSM at $100+ now. "
Actually Evelyn asked? why not 500 or 600 next year" ( last year))).Her $20 by years end(2012) and her $50 dollars after the dog results I used to think were just taunting,but the HGSI analogy says it all....
I have her on Ignore. -
Evelyn OT bottom feeding
see the time of my post? now see my sell now?
"JCP triggered on 2's" 2500@ 16.70
sold 2500 17.14 and out
Now do the Math - its lunch money
You are back on Ignore,but every once in a while a normal poster will engage your nonsense.
How many people here are going to make you look the fool yet once again?
Looks like everyone except kvncmcdd and dorian (zip) ....enough said
Good Luck -
Fud cant read....actually posts about things she has no idea.....
. JCP _ RIGHT NOW triggered on 2's !!!!!!!!!!!!
"I'm currently in discussion with the global Stop TB Partnership, advising them how they should redesign their various therapeutic regimens now that Arikace is available.
When they've finally grasped what they should be doing I'll get in touch with Insmed and give them the benefit of my advice."
Would $165 a share be a fair buyout valuation?
The expectation that the share price will go from the current level to $600 is entirely realistic. Rating :
(9 Ratings)Rate it: fudfighter -
keyser_sooze trading targets
My target is above the 200.The low volume and lack of interest have been reasons I have held(I usually hold a stock like INSM to a min)
hope you get your price.....
Short since $7.81....YTD+24%,.................... the easy money has been made -
Anyone who thinks that Iplex is a part of their INSM investment now is a denier from long ago.
Denial is a very strong emotion. Emotions should never be part of any investment, especially Biotechs.
HARS,GHIS and ALS are disappointments from a different company/not Arikace.
Good Luck -
This mb sentiment indicator is so accurate,its amazing.The trading is simplistic at best, failing the 8,20,24,50...... OT JCP shorts are trapped but earnigs tonight Good Luck